A recently published study in the New England Journal of Medicine shows that 24-hour ambulatory blood pressure monitoring is a better predictor of cardiovascular and all-cause mortality than just ...

Biobeat Technologies, Ltd., developer of the first FDA-cleared, 24-hour ambulatory blood pressure monitoring (ABPM) system that is a patch-worn, cuff-less solution for diagnosis and treatment of ...

Huawei is reportedly preparing to introduce its next smartwatch in India. According to recent leaks, the upcoming wearable may include advanced health tracking features not commonly seen on wrist ...

The BPM Vision doesn't actually work with Withings' Cardio Check-Up—you need an ECG-enabled Withings tracker, like the ...

SEOUL, South Korea, Feb. 10, 2026 /PRNewswire/ -- Sky Labs (CEO Jack Byunghwan Lee) announced on the 10th that it has launched 'CART ON', the world's first ward-specific blood pressure monitoring ...

The number doctors use to demarcate hypertension keeps going down, a trend applauded by many experts, who point to studies ...

Patients with glaucoma who had low 24-hour systemic blood pressure were more likely to lose retinal nerve fiber layer despite well-controlled intraocular pressure.

A pilot program between RWJBarnabas Health and the Liberty Science Center‘s SciTech Scity Healthcare Innovation Engine is showing the vast potential of digital health solutions. Biobeat, a medtech ...

Biobeat Secures $50 Million Series B Financing to Advance Commercialization of its Patch-worn, Cuff-less 24-hour Ambulatory Blood Pressure Monitor Biobeat Technologies, Ltd., developer of the first ...